Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mesenchymal stem cells in infantile haemangioma.
J Clin Pathol. 2011 Mar;64(3):232-6. doi: 10.1136/jcp.2010.085209. Epub 2011 Jan 17.
J Clin Pathol. 2011.
PMID: 21242328
Primitive erythropoiesis in infantile haemangioma.
Itinteang T, Tan ST, Brasch HD, Vishvanath A, Day DJ.
Itinteang T, et al. Among authors: vishvanath a.
Br J Dermatol. 2011 May;164(5):1097-100. doi: 10.1111/j.1365-2133.2010.10187.x.
Br J Dermatol. 2011.
PMID: 21518328
Item in Clipboard
Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).
Vishvanath A, Itinteang T, Tan ST, Day DJ.
Vishvanath A, et al.
Histopathology. 2011 Sep;59(3):397-406. doi: 10.1111/j.1365-2559.2011.03970.x.
Histopathology. 2011.
PMID: 22034880
Item in Clipboard
Infantile haemangioma expresses embryonic stem cell markers.
Itinteang T, Tan ST, Brasch HD, Steel R, Best HA, Vishvanath A, Jia J, Day DJ.
Itinteang T, et al. Among authors: vishvanath a.
J Clin Pathol. 2012 May;65(5):394-8. doi: 10.1136/jclinpath-2011-200462. Epub 2012 Mar 23.
J Clin Pathol. 2012.
PMID: 22447921
Item in Clipboard
Ethnic differences in nicotine metabolic rate among New Zealanders.
Lea R, Benowitz N, Green M, Fowles J, Vishvanath A, Dickson S, Lea M, Woodward A, Chambers G, Phillips D.
Lea R, et al. Among authors: vishvanath a.
N Z Med J. 2005 Dec 16;118(1227):U1773.
N Z Med J. 2005.
PMID: 16372023
Item in Clipboard
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Cheung L, Flemming CL, Watt F, Masada N, Yu DM, Huynh T, Conseil G, Tivnan A, Polinsky A, Gudkov AV, Munoz MA, Vishvanath A, Cooper DM, Henderson MJ, Cole SP, Fletcher JI, Haber M, Norris MD.
Cheung L, et al. Among authors: vishvanath a.
Biochem Pharmacol. 2014 Sep 1;91(1):97-108. doi: 10.1016/j.bcp.2014.05.023. Epub 2014 Jun 25.
Biochem Pharmacol. 2014.
PMID: 24973542
Item in Clipboard
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
Bali P, George P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Scuto A, Annavarapu S, Fiskus W, Moscinski L, Atadja P, Bhalla K.
Bali P, et al. Among authors: vishvanath a.
Clin Cancer Res. 2004 Aug 1;10(15):4991-7. doi: 10.1158/1078-0432.CCR-04-0210.
Clin Cancer Res. 2004.
PMID: 15297399
Item in Clipboard
Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.
George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, Moscinski L, Bhalla K.
George P, et al. Among authors: vishvanath a.
Cancer Res. 2004 May 15;64(10):3645-52. doi: 10.1158/0008-5472.CAN-04-0006.
Cancer Res. 2004.
PMID: 15150124
Item in Clipboard
Cite
Cite